Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farmacosmo SpAMIL:COSMO -2.24%28 3-Year ROIIC % is -631.54 as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 28/100 and a GF Value™ of €0.74 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Farmacosmo SpA ranks worse than 98.06% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Farmacosmo SpA's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -631.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Farmacosmo SpA's 3-Year ROIIC % or its related term are showing as below:
MIL:COSMO's 3-Year ROIIC % is ranked worse than 98.06% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs MIL:COSMO: -631.54
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Farmacosmo SpA 3-Year ROIIC % Related Terms
Farmacosmo SpA 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Farmacosmo SpA's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Farmacosmo SpA's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmacosmo SpA 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Farmacosmo SpA's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Farmacosmo SpA's 3-Year ROIIC % falls into.
Farmacosmo SpA's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -5.473 (Dec. 2025) - -1.3995509 (Dec. 2022) )
/
( 18.584 (Dec. 2025) - 17.939 (Dec. 2022) )
=
-4.0734491
/
0.645
=
-631.54%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Farmacosmo SpA (MIL:COSMO) has a 3-Year ROIIC % of -631.54 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Farmacosmo SpA and its competitors. According to the industry distribution chart, Farmacosmo SpA ranks #607 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 98.1%.
Is Farmacosmo SpA's 3-Year ROIIC % too high?
Farmacosmo SpA's current 3-Year ROIIC % is -631.54. Based on the distribution chart, Farmacosmo SpA ranks #607 out of 619 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Farmacosmo SpA has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Farmacosmo SpA ranks #607 out of 619 companies for 3-Year ROIIC %. This places Farmacosmo SpA in the lower half of its industry. The industry median 3-Year ROIIC % is 3.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Farmacosmo SpA and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmacosmo SpA's current 3-Year ROIIC % is -631.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.74, compared to a current price of €0.48 — trading 35.3% below its estimated fair value. The current 3-Year ROIIC % is -631.54. Farmacosmo SpA's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current 3-Year ROIIC % is -631.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?
Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued.
The current stock price of €0.48 is trading 35.3% below its estimated GF Value™ of €0.74.
GuruFocus considers Farmacosmo SpA to be Possible Value Trap.
Key valuation signals for MIL:COSMO:
3-Year ROIIC %: -631.54
GF Value™: €0.74 vs. price of €0.48 (35.3% below fair value)
No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
28GF Score
Get the complete analysis for MIL:COSMO
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:COSMO has been successfully added to your 
